Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation. 1995

M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
Department of Paediatrics, Virology, and Surgery, Cliniques St Luc, Catholic University of Louvain, Brussels, Belgium.

Paediatric orthotopic liver transplant recipients may develop chronic hepatitis after surgery. To investigate the role of hepatitis C virus in this pathology a cohort of 249 paediatric orthotopic liver transplant recipients was studied. Sixteen children (6.4%) were found to have chronic hepatitis C virus hepatitis after orthotopic liver transplantation. All but one of them had serum transaminase values which were persistently raised two to eight times the upper limit of normal. Thirteen were positive for both serology and serum hepatitis C virus RNA. Serum hepatitis C virus RNA detection occurred five to 33 months before hepatitis C virus antibodies. Liver tissue hepatitis C virus RNA and hepatitis C virus core antigen were detected in five. In one patient, tissue hepatitis C virus core antigen was detected when other tests for hepatitis C were negative. Two patients had positive human cytomegalovirus serum antibodies and RNA before transplantation. Although serum hepatitis C virus RNA was not detected after transplantation, serum enzyme immunosorbent assay and tissue core antigen were still detectable in both patients. In another child, serum hepatitis C virus RNA was positive and hepatitis C virus core antigen was found on a liver biopsy specimen but antihepatitis C virus antibodies were negative as well as liver hepatitis C virus RNA. No patient developed severe liver disease or cirrhosis during a follow up of up to 72 months. It is concluded that hepatitis C virus is a significant cause of morbidity after paediatric orthotopic liver transplantation. Diagnosis cannot rely on serological testing only. The patients remained stable on follow up, but longer prospective histological studies remain necessary to establish prognosis.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
February 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
June 2011, Transplantation,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
January 1999, The new microbiologica,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
November 1992, Hepatology (Baltimore, Md.),
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
February 1997, Gastroenterology,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
October 1992, Transplantation,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
April 1991, Hepatology (Baltimore, Md.),
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
January 1997, Transplantation proceedings,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
May 1998, Journal of hepatology,
M Pastore, and M Willems, and C Cornu, and J P Buts, and R Reding, and J de Ville de Goyet, and J Rahier, and J B Otte, and S H Yap, and E M Sokal
November 2003, Transplantation,
Copied contents to your clipboard!